IRB-Brasil Resseguros S.A.

What it is

IRB(Re) is Brazil’s leading reinsurer, providing life, retirement, and non-life reinsurance services across aviation, property, agriculture, oil and gas, marine, and more. Its customers are not households but insurance companies: when a Brazilian insurer takes on a risk too large to hold alone, it passes part of that exposure to IRB(Re) in exchange for a share of the premium.

IRB-Brasil Resseguros was incorporated in 1939 as a state-owned monopoly, losing its monopoly in 2007, ending 69 years without domestic competition. It was privatised in 2013 and listed on the B3 in July 2017.

Brazil accounts for about 50.8% of written premiums, with the rest spread across Latin America and, selectively, global markets through its London branch.

Who owns it

The structured data shows insiders hold 32.6% of shares and institutional investors a further 23.4%, leaving roughly 44% as free float (our calculation). Since October 2013, the controlling shareholders alongside the Brazilian Federal Government include BB Seguros Participações, Bradesco Auto Re, Itaú Seguros, Itaú Vida e Previdência, and the Caixa Barcelona investment fund.

The Federal Government retains a “golden share” — a special class of stock that gives it veto power over certain strategic decisions — and nominates the board chairman. Former Minister of State Mauricio Quintella Malta Lessa holds the position of Board of Directors Chairman, appointed by the Federal Union as the holder of the golden share.

Who runs it

Marcos Pessôa de Queiroz Falcão serves as Chief Executive Officer and Investor Relations Officer. The Board appointed Frederico Knapp as Chief Financial Officer in December 2024.

Knapp has been active in insurance since 2001 and spent ten years at Swiss Re, including as President of Swiss Re Brasil and CFO/COO. Both appointments signal a deliberate effort to bring in market-tested operators as the company rebuilds its credibility.

The money, in plain words

IRB(Re) keeps about 6.8 cents of profit from every real of revenue — a net profit margin of 6.8%, modest by global reinsurance standards but a genuine recovery from the losses of 2022–2023. For every real that shareholders own in the business, it earns back roughly 6.7 cents a year — a return on equity of 6.7%, still below the 20% long-term target management has publicly set.

At 12.1 times earnings (price-to-earnings ratio of 12.1×), the market is paying a below-average multiple, consistent with a company still proving its rehabilitation. The regulatory solvency ratio climbed from 169% in early 2024 to 268% by end-2025 — meaning the company holds more than two and a half times the capital regulators require, a buffer that gives it room to grow premiums without raising fresh equity.

Net financial debt is a modest R$265m / US$52m (our calculation: debt of R$277m (US$54 mn) minus cash of R$11m (US$2 mn)), very light for a financial firm of this size.

What it is doing now

Full-year 2025 net income rose 35% to R$505m (US$98m), with the combined ratio — the share of every premium spent on claims and costs — falling to 95%, meaning it finally earns more from underwriting than it pays out. The company’s strategic exit from unprofitable life reinsurance contracts drove improved profitability and a positive underwriting result in life for the third straight quarter.

IRB(Re) proposed its first dividend in five years for early 2026, alongside a new stock-based incentive plan and a share buyback programme. Credit agency AM Best affirmed its A− (Excellent) rating and S&P Global upgraded IRB Brasil from ‘brAA+’ to ‘brAAA’ on the Brazil national scale.

What to watch

• ROE gap. Management targets a long-term return on tangible equity of around 20%; it stood at 22% in 2025 on a tangible basis — but the headline ROE of 6.7% (our calculation from EODHD data) reflects goodwill and the full equity base. Closing this gap, and sustaining it, is the central test.
• Life segment rebuild. Management plans to grow life reinsurance from 4% to 20–22% of the portfolio within two to three years, a transformation that will require careful underwriting after the prior losses in that line.
• Expense creep. The administrative expense ratio surged to 14.0% in mid-2025 from 8.5% a year earlier, driven by technology investment — legitimate but a number analysts are watching closely.
• Golden share overhang. The Federal Government’s veto right limits the scope for transformative M&A and could affect governance, an issue the ISS shareholder-rights pillar score of 8 out of 10 (high risk) already flags.

This is news, not investment advice.